Maytas Infra posts Rs.490 crore lossAugust 31st, 2009 MUMBAI - Infrastructure company Maytas Infra posted a net loss of Rs.489.79 crore last fiscal compared to a profit of Rs.99.64 crore in the previous period, it said in a regulatory statement Monday. The Hyderabad-based company, promoted by the family of B.
Tata Motors posts Rs.329 crore loss in Q1August 31st, 2009 MUMBAI - The high-priced acquisition of Jaguar Land Rover (JLR) and dipping volumes have taken their toll on Tata Motors, which reported a loss of Rs.328.78 crore in the first quarter ended June 30, as compared to a profit of Rs.719.69 crore logged in the same quarter the previous fiscal. The company's consolidated gross revenue for the first quarter of the current fiscal stood at Rs.16,953.63 crore, while it was Rs.15,496.28 crore in the year-ago period.
Kingfisher posts Rs.1,608 crore lossAugust 5th, 2009 NEW DELHI - Private carrier Kingfisher Airlines has reported a net loss of Rs.1,608.09 crore ($338.5 million) for 2008-09, but said it has plans to raise Rs.500 crore from the equity market. The airline's expenses on employees cost stood at Rs.823.85 crore last fiscal, while expenses on aviation fuel and aircraft lease rental were respectively at Rs.2,602 crore and Rs.1,185.13 crore, Kingfisher said in a regulatory statement Wednesday.
Suzlon posts net loss of Rs.160 crore in first quarterAugust 1st, 2009 MUMBAI - Wind power major Suzlon posted a net loss of Rs.160.47 crore for the quarter ended June 30, compared to a net profit of Rs.88.04 crore in the same period the previous fiscal. The company logged a total income of Rs.359.32 crore in the first quarter, a decrease of 75 percent from Rs.1,496.28 crore in the year-ago period.
Hinduja Foundries posts Rs.10 crore lossJuly 29th, 2009 CHENNAI - Hinduja Foundries, part of the diversified Hinduja Group, has posted a net loss of Rs.10.44 crore in the quarter ended June 30 as against a profit of Rs.4.57 crore in the like period last year. The company's turnover for the first quarter stood at Rs.67.03 crore as compared to Rs.125.20 crore a year ago, a fall of 46 percent.
Ranbaxy to set up third unit in Himachal PradeshJuly 27th, 2009 SHIMLA - Pharmaceutical major Ranbaxy and fast moving consumer goods manufacturer Proctor and Gamble (P&G) are among nine companies that have been allowed to set up units in Himachal Pradesh, a senior official said Monday. "Ranbaxy and Procter and Gamble (P&G) Monday got permission from the state government to set up units in the state," industries director Manoj Kumar told IANS.
Tata Motors posts Rs.2,505 crore lossJune 26th, 2009 MUMBAI - Leading vehicle maker Tata Motors has posted a huge loss of Rs.2,505.25 crore ($520 million) in 2008-09 as against a profit of Rs.2,167.7 crore recorded the year before, thanks to the global slowdown and losses made by its British unit. Its turnover, however, almost doubled to Rs.70,938.85 crore last year from Rs.35,660.07 crore in 2007-08, the company said in a statement.
McLeod Russel posts net loss of Rs.88.61 croreJune 3rd, 2009 KOLKATA - Tea plantation company McLeod Russel Wednesday said its net loss has come down to Rs.88.61 crore for the fourth quarter of 2008-09. The company had posted a loss of Rs.97.34 crore in the January-March quarter of 2007-08, an official statement said.
Jet posts last quarter profit, though income dipsMay 25th, 2009 NEW DELHI - India's largest private carrier Jet Airways Monday announced a net profit of Rs.52.99 crore for the quarter ending March 31, as compared to a net loss of Rs.221 crore in the corresponding period in 2007-08. The total income of the company, however, decreased to Rs.2,566 crore in the quarter under review, as compared to Rs.2,796 crore posted in the year-ago period, the company said in a regulatory statement.
Malvinder Singh steps down as Ranbaxy chief executiveMay 24th, 2009 NEW DELHI - Malvinder Mohan Singh has stepped down as chairman, managing director and chief executive of India's largest pharmaceuticals company, Ranbaxy Laboratories, which was acquired last year by Japan's Daiichi Sankyo. Atul Sobti, the current chief operating officer, has been appointed as chief executive and managing director, while Tsutomu Une, the company's non-executive director, will now serve as its chairman, a company statement said.
Ceat posts loss of Rs.16 crore in 2008-09April 29th, 2009 NEW DELHI - Tyre maker Ceat Ltd Wednesday reported a loss of Rs.16.12 crore for the year ended March 31, 2009, even as the company's total income rose by a marginal 8 percent from the year before. In 2007-08, the company had posted a net profit of Rs.148 crore.
Tech Mahindra posts Rs.221 crore net profit in Q4April 27th, 2009 NEW DELHI - IT services exporter Tech Mahindra, which is taking over the fraud-hit IT giant Satyam Computer Services, Monday reported a net profit of Rs.221.3 crore for the fourth quarter of 2008-09. The company had reported a loss of Rs.207.07 crore in the corresponding period in 2007-08 after it accounted for one-time expense of Rs.440 crore, an official statement said.
Poll expense on rise - from Rs.104.5 mn to Rs.13 bnMarch 4th, 2009 NEW DELHI - Since India's first Lok Sabha elections in 1952 to the last round in 2004, poll expenses have shot up from Rs.104.5 million to Rs.13 billion. And this time, for the April-May exercise, the figure is likely to be even higher, says official data.
Ranbaxy posts Rs.6.8 bn losses in fourth quarterJanuary 21st, 2009 NEW DELHI - Leading drug maker Ranbaxy Laboratories Thursday reported a net loss after tax of Rs.6.8 billion for the quarter ended Dec 31, against a profit of Rs.1.88 billion during the like period the previous year,
The company reported a net loss of Rs.9.14 billion (Rs.914.6 crore) for the financial year ended Dec 31, as compared to a net profit of Rs.7.87 billion (Rs.786.6 crore) the previous year. Ranbaxy attributed the losses to currency fluctuations and adopting of new accounting standards.
Daiichi says Ranbaxy acquisition will hit its bottomlineJanuary 4th, 2009 NEW DELHI - Japanese drug maker Daiichi Sankyo will take a hit on its books owing to its acquisition of Indian pharmaceutical major Ranbaxy Laboratories, a Daiichi company statement said Monday. In the statement, Daiichi Sankyo also said it planned to record a valuation loss and one-time write down of goodwill on its investment in the now group subsidiary Ranbaxy.